ScoreComparison
Why is InMed Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Negative results in Mar 26
- NET SALES(HY) At USD 0.82 MM has Grown at -65.44%
- OPERATING CASH FLOW(Y) Lowest at USD -7.71 MM
- ROCE(HY) Lowest at -119.82%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -38.78%, its profits have risen by 3.2%
4
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 22.24% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -38.78% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is InMed Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
InMed Pharmaceuticals, Inc.
-38.78%
4.36
155.88%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
40.68%
EBIT Growth (5y)
-2.74%
EBIT to Interest (avg)
-9.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.50
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.11%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.20
EV to EBIT
0.60
EV to EBITDA
0.64
EV to Capital Employed
-1.56
EV to Sales
-1.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-79.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at USD -4.82 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 6.54 times
-18What is not working for the Company
NET SALES(HY)
At USD 0.82 MM has Grown at -65.44%
OPERATING CASH FLOW(Y)
Lowest at USD -7.71 MM
ROCE(HY)
Lowest at -119.82%
OPERATING PROFIT(Q)
Lowest at USD -2.68 MM
PRE-TAX PROFIT(Q)
Lowest at USD -2.79 MM
NET PROFIT(Q)
Lowest at USD -2.79 MM
Here's what is working for InMed Pharmaceuticals, Inc.
Inventory Turnover Ratio
Highest at 6.54 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for InMed Pharmaceuticals, Inc.
Net Sales
At USD 0.82 MM has Grown at -65.44%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Operating Cash Flow
Lowest at USD -7.71 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Operating Profit
Lowest at USD -2.68 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -2.79 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Pre-Tax Profit
Fallen at -31.63%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -2.79 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Profit
Fallen at -31.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
